BCP Journal Club Seminar: “Structure-Based Drug Design: Case Studies in Breast cancer and SARS-CoV-2”


12:30 to 1:30 p.m., Jan. 19, 2023
Dr. Rui Xiong

Abstract: Dr. Xiong’s research interest is directed toward applying medicinal chemistry tools to understanding and modulating human diseases. He will present the story of discovering Rintodestrant, an estrogen receptor degrader currently in clinical trials for advanced breast cancer. Additionally, he will report on the recent progress in discovering SARS-CoV-2 PLpro inhibitors.  


Chavez, room 405


Dr. Rui Xiong Professor, Department of Pharmacology and Toxicology, The University of Arizona